Infinity Pharmaceuticals, Inc.
INFI
INFI was delisted on the 13th of September, 2023.
107 hedge funds and large institutions have $53.9M invested in Infinity Pharmaceuticals, Inc. in 2016 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 31 increasing their positions, 36 reducing their positions, and 31 closing their positions.
983% more call options, than puts
Call options by funds: $390K | Put options by funds: $36K
9% less funds holding
Funds holding: 117 → 107 (-10)
14% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 36
29% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 31
78% less capital invested
Capital invested by funds: $241M → $53.9M (-$187M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$24.2M |
| 2 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$3.45M |
| 3 |
Renaissance Technologies
New York
|
+$3.45M |
| 4 |
IGIM
I.G. Investment Management
Winnipeg,
Manitoba, Canada
|
+$3.27M |
| 5 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
+$1.36M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
-$14.2M |
| 2 |
DM
Deerfield Management
New York
|
-$11.5M |
| 3 |
Goldman Sachs
New York
|
-$6.86M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$6.19M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.98M |
INFI Hedge Fund Activity: Q2 2016 in Review
107 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Infinity Pharmaceuticals, Inc. (INFI) for Q2 2016, worth a combined $53.9M — down 78% from $241M a quarter earlier.
Sellers outnumbered buyers: 31 funds closed out of INFI and 22 opened new positions — a net loss of 9 holders — while 36 trimmed existing stakes and 31 added.
The largest buyer was BVF Inc, opening a new position worth an estimated $24.2M. The largest seller was BB Biotech, exiting entirely with an estimated $14.2M sold.
- 107 institutional investors held Infinity Pharmaceuticals, Inc. (INFI) as of Q2 2016, down from 117 in Q1 2016.
- Funds reported $53.9M of Infinity Pharmaceuticals, Inc. stock for Q2 2016, down 78% quarter-over-quarter.
- 22 funds opened new Infinity Pharmaceuticals, Inc. positions in Q2 2016 and 31 closed out, a net change of -9 holders.
- The largest Infinity Pharmaceuticals, Inc. buyer in Q2 2016 was BVF Inc, an estimated $24.2M added.
- The largest Infinity Pharmaceuticals, Inc. seller in Q2 2016 was BB Biotech, an estimated $14.2M sold.
Based on aggregated 13F filings for Q2 2016.